Erythroderma Open Access Journals

Erythroderma or exfoliative dermatitis is peeling of the skin over large areas of the body. The term “exfoliative” refers to the exfoliation, or shedding, of the skin. “Dermatitis” means irritation of the skin. The skin peeling is associated with pre-existing medical conditions in some people, while in others the cause is unknown. Exfoliative dermatitis, sometimes called erythroderma, is serious but fairly uncommon. Complications are infection, loss of nutrients, and dehydration. The root cause of exfoliative dermatitis or erythroderma is a disorder of the skin cells. The cells die and shed too quickly in a process called “turning over.” The rapid turnover of skin cells causes significant peeling and scaling of the skin. The peeling and scaling is also described as “sloughing.” Many people suffered from chronic skin conditions, including autoimmune diseases, psoriasis, and eczema, will also develop exfoliative dermatitis. Adverse reactions to a variety of drugs could also contribute to massive skin scaling. Severe symptoms of erythroderma or exfoliative dermatitis will be life threatening. Mortality rates are highest in patients with infection, fluid and electrolyte abnormalities, and cardiac failure. The most common causes of death in patients with erythroderma or exfoliative dermatitis are pneumonia, septicemia, and heart failure The top open access journals are peer reviewed scholarly journals of Journal of Hair: Therapy & Transplantation. The top open access journals are freely available on the public internet domain, allowing any end users to read, download, copy, distribute, prink, search or link to the full texts of the articles. These provide high quality, meticulously reviewed and rapid publication, to cater the insistent need of scientific community. These journals are indexed with all their citations noted. The top open access journals are indexed in MEDLINE, PUBMED, SCOPUS, COPERNICUS, CAS, EBSCO and ISI.

• Share this page
• 
• 
• 
• 
• 
• 

Last date updated on April, 2024